Business Wire1mon
A2 Bio Highlights Progress of Tmod™ CAR T-Cell Clinical Programs During 2024 Annual Meeting of the Society for Immunotherapy of Cancer
HOUSTON--(BUSINESS WIRE)--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company ... participants enrolled in the BASECAMP-1 nationwide prescreening study for all Tmod™ CAR ...
Morningstar1mon
A2 Bio Highlights Progress of Tmod™ CAR T-Cell Clinical Programs During 2024 Annual Meeting of the Society for Immunotherapy of Cancer
A2 Bio shares enrollment updates on EVEREST-1 and EVEREST-2 clinical studies A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy ... BASECAMP-1 nationwide prescreening study for ...